Female menstrual cycle monitoring rings are smart wearable devices specifically designed for women, primarily used to track and monitor women's menstrual cycles. They fall under the category of medical devices and require registration and approval from the National Medical Products Administration (NMPA) for market entry in China, FDA approval for the US market, and CE certification followed by registration for the European market.

Below is an overview of the FDA registration process for such female menstrual cycle monitoring rings:

I. Determine Product Classification

The FDA classification of smart wearable products depends on their functions:

• Class I: Low-risk devices (e.g., regular fitness trackers).

• Class II: Moderate-risk devices (e.g., products with medical functions such as heart rate monitoring and blood oxygen monitoring).

• Class III: High-risk devices (e.g., devices for life support or diagnosis, typically not involved in smart wearable products).

Steps:

1. Define the intended use and indications for use of the product.

2. Search the FDA's Product Classification database for the corresponding product classification code and regulation number.

II. Determine Registration Pathway

Based on the product classification, select the appropriate registration pathway:

• 510(k) Premarket Notification: Applicable to most Class II devices, requiring proof of substantial equivalence to a legally marketed predicate device.

• De Novo Application: Applicable to novel Class I or Class II devices without a predicate device for comparison.

• PMA (Premarket Approval): Applicable to Class III devices, typically not involved in smart wearable products.

Steps:

1. Determine whether a 510(k) or De Novo application is required.

2. Prepare corresponding technical documents and test data.

3. Establish a quality management system.

The FDA requires medical device manufacturers to comply with 21 CFR Part 820 (Quality System Regulation, QSR), also known as Good Manufacturing Practices (GMP).

III. Prepare Technical Documents

Establish a quality management system (QMS) that meets FDA requirements, ensuring compliance with GMP in design control, production processes, supplier management, and document control. Prepare technical documents, which are the core of the FDA registration and must include:

• Product description: Functionality, intended use, indications, technical specifications, etc.

• Performance test reports: Electrical safety, electromagnetic compatibility (EMC), biocompatibility (if applicable), etc.

• Software verification and validation: If the product contains software, provide software requirements specifications, verification test reports, etc.

• Clinical data (if applicable): Provide clinical trial reports if clinical data is required to support the product.

• Labels and instructions: Include product labels, user manuals, packaging labels, etc., complying with 21 CFR Part 801.

Testing standards in the US include:

Region	Item	Standard
USA	Safety	IEC 60601-1:2005/AMD2:2020, IEC 60601-1-11:2015/AMD1:2020, IEC 60601-1-8:2006/AMD2:2020
USA	EMC	IEC 60601-1-2:2014/AMD1:2020
USA	Performance  (specific standards)	Body temperature: EN ISO 80601-2-56:2017/AMD1:2018; Blood pressure: IEC 80601-2-30:2018; ECG: IEC 60601-2-47:2012/EN 60601-2-47:2015; Blood oxygen: ISO 80601-2-61:2017/EN ISO 80601-2-61:2019
USA	Biocompatibility	EN ISO 10993-23:2021
USA	Cleaning, disinfection, sterilization	AAMI TIR12:2020, AAMI ST98:2022, ISO 15883-5:2021, ISO 15883-6:2011
USA	Cybersecurity	(Not specified)

Clinical evaluations are required for modules such as blood pressure, blood oxygen, body temperature, atrial fibrillation, and respiratory rate to demonstrate product safety, effectiveness, and accuracy.

IV. Submit 510(k) Application

If a 510(k) application is required, complete the following steps:

1. Fill out the FDA form, including the 510(k) application form (Form 3654).

2. Prepare a 510(k) summary outlining the product's technical characteristics, test results, and substantial equivalence analysis.

3. Submit the application through the FDA's electronic submission portal (eSubmitter or CDRH Portal).

4. Pay the fee according to the FDA's fee schedule (standard fee in 2023 is approximately $19,870).

V. FDA Review

The FDA will review the submitted 510(k) application, typically taking around 90 days:

1. Initial review: FDA confirms the completeness of the application documents.

2. Technical review: FDA reviews technical documents, test data, and substantial equivalence analysis.

3. Feedback and supplements: If the FDA identifies issues, it will issue a Deficiency Letter, requiring supplementary materials within a specified timeframe.

VI. Obtain FDA Approval

• If the 510(k) application is approved, the FDA will issue a 510(k) Clearance Letter, allowing the product to be marketed in the US.

• If the application is rejected, it must be revised based on FDA feedback and resubmitted.

VII. Establishment Registration and Device Listing

After obtaining 510(k) approval, complete the following steps:

1. Establishment Registration: Register the establishment through the FDA's FURLS system to obtain an Establishment Registration Number.

2. Device Listing: List the product in the FDA system to obtain a Device Listing Number.

3. Annual Updates: Annually update the establishment registration and device listing information.

VIII. Post-market Surveillance

After product launch, comply with the FDA's post-market surveillance requirements:

• Medical Device Reporting (MDR): Report product-related adverse events according to 21 CFR Part 803.

• Recall Management: Conduct recalls as required by the FDA if issues arise with the product.

• Periodic Audits: FDA may conduct on-site audits to ensure compliance with GMP.

IX. Other Considerations

• UDI (Unique Device Identifier): Medical devices must bear a UDI code and be registered in the GUDID database according to FDA requirements.

• Cybersecurity: If the product involves data transmission or storage, it must comply with FDA cybersecurity guidelines.

• Label and Advertising Compliance: Ensure product labels and advertising content comply with FDA requirements, avoiding false or misleading claims.

Summary of FDA Registration Process for Smart Wearable Products

1. Determine product classification (Class I/II/III).

2. Select registration pathway (510(k)/De Novo/PMA).

3. Establish a quality management system (QMS/GMP).

4. Prepare technical documents (product description, test reports, software verification, etc.).

5. Submit a 510(k) application (including forms, summaries, fees).

6. Undergo FDA review (typically 90 days).

7. Obtain FDA approval (510(k) Clearance Letter).

8. Complete establishment registration and device listing (FURLS system).

9. Comply with post-market surveillance requirements (MDR, recalls, periodic audits).

By following these steps, you can successfully complete the FDA registration process for smart wearable products and enter the US market. 

For further support, it is advisable to consult professional FDA registration consultants such as HOM Medical. 

HOM Medical will plan the entire registration pathway based on the actual situation of the enterprise, collaborate on teamwork, registration materials, system construction, registration testing, simultaneously organize clinical data requirements, contact research institutions, initiate clinical accuracy verification upon completion of testing reports, submit registrations simultaneously, undergo on-site inspections, address supplementary requests, obtain registrations, and complete the entire registration project, thereby shortening the overall registration process.

鸿盟医学

医疗器械全球注册咨询、医疗器械临床试验、医疗器械质量管理体系（ISO13485/GMP/QSR）、医疗器械可用性研究、

医疗器械法规培训众多的专业技术服务咨询机构

微信号：hom_medical、18018710006 联系电话：18018716006